A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors

NCT07110883 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: SYS6023

Sponsor

CSPC Megalith Biopharmaceutical Co.,Ltd.